CGNL1
Basic information
Region (hg38): 15:57375967-57550717
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CGNL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | |||||
missense | 118 | 13 | 136 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 3 | |||||
Total | 0 | 0 | 118 | 22 | 9 |
Variants in CGNL1
This is a list of pathogenic ClinVar variants found in the CGNL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-57438044-T-C | CGNL1-related disorder | Likely benign (Jan 27, 2020) | ||
15-57438096-C-A | not specified | Uncertain significance (Dec 03, 2021) | ||
15-57438110-A-G | CGNL1-related disorder | Likely benign (Apr 19, 2019) | ||
15-57438120-G-C | not specified | Uncertain significance (Apr 07, 2023) | ||
15-57438184-G-C | not specified | Uncertain significance (Nov 22, 2022) | ||
15-57438189-C-G | not specified | Uncertain significance (Feb 06, 2024) | ||
15-57438202-C-G | not specified | Uncertain significance (Jul 25, 2023) | ||
15-57438217-G-A | not specified | Uncertain significance (Mar 28, 2024) | ||
15-57438232-C-A | not specified | Uncertain significance (Dec 21, 2023) | ||
15-57438293-T-G | not specified | Uncertain significance (May 24, 2023) | ||
15-57438318-C-G | not specified | Uncertain significance (Jan 23, 2024) | ||
15-57438330-C-A | not specified | Uncertain significance (Apr 06, 2024) | ||
15-57438334-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
15-57438339-A-G | not specified | Likely benign (Aug 13, 2021) | ||
15-57438388-T-G | not specified | Uncertain significance (Jun 16, 2024) | ||
15-57438393-C-G | not specified | Uncertain significance (Feb 08, 2023) | ||
15-57438397-A-G | not specified | Uncertain significance (Nov 24, 2024) | ||
15-57438420-C-T | not specified | Uncertain significance (Feb 28, 2024) | ||
15-57438444-C-T | not specified | Uncertain significance (Feb 05, 2024) | ||
15-57438459-C-A | CGNL1-related disorder | Uncertain significance (Feb 05, 2024) | ||
15-57438504-C-A | not specified | Uncertain significance (Oct 12, 2024) | ||
15-57438504-C-G | not specified | Uncertain significance (Apr 12, 2024) | ||
15-57438505-C-T | not specified | Uncertain significance (Jul 26, 2021) | ||
15-57438624-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
15-57438637-T-C | not specified | Uncertain significance (Sep 17, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CGNL1 | protein_coding | protein_coding | ENST00000281282 | 18 | 174761 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.69e-42 | 7.59e-7 | 125541 | 1 | 206 | 125748 | 0.000823 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -2.02 | 881 | 728 | 1.21 | 0.0000442 | 8553 |
Missense in Polyphen | 242 | 211.99 | 1.1416 | 2541 | ||
Synonymous | -0.870 | 320 | 301 | 1.06 | 0.0000189 | 2468 |
Loss of Function | -0.0509 | 63 | 62.6 | 1.01 | 0.00000349 | 748 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00304 | 0.00302 |
Ashkenazi Jewish | 0.000303 | 0.000298 |
East Asian | 0.000925 | 0.000925 |
Finnish | 0.000370 | 0.000370 |
European (Non-Finnish) | 0.000416 | 0.000413 |
Middle Eastern | 0.000925 | 0.000925 |
South Asian | 0.000852 | 0.000850 |
Other | 0.00261 | 0.00261 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in anchoring the apical junctional complex, especially tight junctions, to actin-based cytoskeletons. {ECO:0000269|PubMed:22891260}.;
- Disease
- DISEASE: Aromatase excess syndrome (AEXS) [MIM:139300]: An autosomal dominant disorder characterized by increased extraglandular aromatization of steroids that presents with heterosexual precocity in males and isosexual precocity in females. {ECO:0000269|PubMed:12736278}. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration inv(15)(q21.2;q21.3) has been found in patients with aromatase excess syndrome. The inversion moves the promoter of the CGNL1 gene into a 5-prime position in relation to the aromatase coding region.;
- Pathway
- Tight junction - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- loftool
- 0.903
- rvis_EVS
- 0.33
- rvis_percentile_EVS
- 73.43
Haploinsufficiency Scores
- pHI
- 0.134
- hipred
- N
- hipred_score
- 0.329
- ghis
- 0.488
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.735
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | High |
Mouse Genome Informatics
- Gene name
- Cgnl1
- Phenotype
Gene ontology
- Biological process
- actin filament organization;negative regulation of small GTPase mediated signal transduction
- Cellular component
- bicellular tight junction;myosin complex
- Molecular function
- motor activity;protein binding